Angiodiabetica
- Address
- Ul. Przemyslowa 46a/u3, 61-541 Poznan, Poland
Angiodiabetica Klinika Chorob Naczyn I Stopy Cukrzycowej Sp. z o.o.
Angiodiabetica Klinika is a specialized medical research center dedicated to vascular diseases and diabetic foot complications. The clinic focuses on advancing treatment options for patients suffering from complex diabetic complications, with particular expertise in managing severe infections and vascular pathologies associated with diabetes mellitus.
- Diabetic foot infections and wound management
- Advanced antimicrobial therapy evaluation
- Vascular disease treatment and prevention
The center actively participates in international Phase 3 clinical trials evaluating novel antibiotic therapies for moderate to severe diabetic foot infections. Their research portfolio includes comparative studies of innovative antimicrobial agents such as contezolid acefosamil and contezolid against standard-of-care treatments, contributing to the development of more effective therapeutic strategies for patients with diabetic foot complications. The clinic's comprehensive approach combines clinical research excellence with specialized care in vascular medicine and diabetic foot pathology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Angiodiabetica
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of Topical Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers Infected by Acinetobacter baumannii, Pseudomonas aeruginosa, or Staphylococcus aureus | Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A. | Phase II | Not Recruiting | — | Dec 2025 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| F1245/05 | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.